NCT06001853 - Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 3, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Facet-Mediated Low Back Pain

Interventions

DRUG

BM-MSC injection

BM-MSCs at the dose 10 x 106 in 1 ml per facet joint for a total of 2 joints

DRUG

DSMO Injection

After 6 months, patients randomized to Arm B: DMSO will be unblinded and re-assigned to Arm A: treatment then be followed for 12 months.

Trial Locations (1)

RECRUITING

Mayo Clinic in Florida, Jacksonville